Drugs / MMRII
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00000815 | ? → Aug 2001 | HIV infectious disease, measles | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M-M-R-II | “measles, mumps, and rubella, live attenuated (MMRII) vaccine at 12 months of age” PMID 21666159 ↗ Jul 20111“Biological: M-M-R-II” NCT00000815 ↗ |
| Modality | Vaccine | “measles, mumps, and rubella, live attenuated (MMRII) vaccine” PMID 21666159 ↗ Jul 2011 |
| Route | Subcutaneous | “administered subcutaneously” NCT00000815 ↗ |